Poverty and chronic diseases in Asia: Challenges and opportunities

CMAJ. Canadian Medical Association Journal

Volumn 177, Issue 9, 2007, Pages 1059-1062

  Jha, Prabhat ^a   Chen, Zhengming ^b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ANTIHYPERTENSIVE AGENT; HEPATITIS B VACCINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TUBERCULOSTATIC AGENT; WART VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASIA; CAUSE OF DEATH; CHILDHOOD MORTALITY; CHRONIC DISEASE; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DISEASE CONTROL; HEART INFARCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CANCER; MATERNAL MORTALITY; MORTALITY; NONHUMAN; NOTE; OBESITY; ORAL REHYDRATION THERAPY; PAPANICOLAOU TEST; POVERTY; RECURRENT DISEASE; SMOKING; SMOKING CESSATION; SOUTH ASIA; STROKE; TUBERCULOSIS; UTERINE CERVIX CANCER; VASCULAR DISEASE; WART VIRUS;

EID: 35848966582     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.071275     Document Type: Note

References (26)

1. Wolf M. What India must do to outpace China. Fin Times [New York] 2006 Feb 14.
2. Tandon A. Attaining millennium development goals in health: Isn't economic growth enough? no. 35 of Economics and Research Department policy brief series. Manila (Philippines): Asian Development Bank; 2005. Available: www.adb.org/Documents/EDRC/Policy_Briefs/PBo35.pdf (accessed 2007 Sept 24).
3. Jha P, Anderson I. Reducing adult deaths from chronic diseases in Asia: evidence and opportunities. Washington: The World Bank Group, Disease Control Priorities Project; 2007. Available: http://www.dcp2.org/features/49 (accessed 2007 Sept 28).
4. Lopez AD, Mathers CD, Ezzati M, et al, editors. Global burden of disease and risk factors. Washington: World Bank Publications; 2006.
5. Jha P. Avoidable mortality in India: past progress and future prospects. Natl Med J India 2002;15 Suppl 1:32-6.
6. Peto R. Statistics of chronic disease control. Nature 1992;356:557-8.
7. Jamison DT, Measham AR, Breman JB, et al, editors. Disease control priorities in developing countries. 2nd ed. New York: Oxford University Press; 2006. Available: http://files.dcp2.org/pdf/DCP/DCP01.pdf (accessed 2007 Sept 24).
8. Jamison DT. Investing in health. In: Jamison DT, Measham AR, Breman JB, et al, editors. Disease control priorities in developing countries. 2nd ed. New York: Oxford University Press; 2006. p. 3-34. Available: http://files.dcp2.org/pdf/DCP/DCP01.pdf (accessed 2007 Sept 24).
9. Bobak M, Jha P, Nguyen S, et al. Poverty and smoking. In: Jha P, Chaloupka FJ, editors. Tobacco control in developing countries. Oxford: Oxford University Press; 2000. p. 41-61.
10. Bonu S, Rani M, Jha P, et al. Household tobacco and alcohol use, and child health: an exploratory study from India. Health Policy 2004;70:67-83.
11. van Doorslaer E, O'Donnell O, Rannan-Eliya RP, et al. Effect of payments for health care on poverty estimates in 11 countries in Asia: an analysis of household survey data. Lancet 2006;368:1357-64.
12. Liu BQ, Peto R, Chen ZM, et al. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ 1998;317:1411-22.
13. Gajalakshmi V, Peto R, Kanaka TS, et al. Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls. Lancet 2003;362:507-15.
14. Jha P, Chaloupka FJ, Moore J, et al. Tobacco addiction. In: Jamison DT, Measham AR, Breman JB, et al, editors. Disease control priorities in developing countries. 2nd ed. New York: Oxford University Press; 2006. p. 869-85. Available: http://files.dcp2.org/pdf/DCP/DCP46.pdf (accessed 2007 Sept 24).
15. Peto R, Lopez AD, Boreham J, et al. Mortality from smoking in developed countries, 1950-2000. 2nd ed. Oxford (UK): Clinical Trial Service Unit and Epidemiological Studies Unit; 2006. Available: http://www.ctsu.ox.ac.uk/ ~tobacco/ (accessed 2007 Sept 24).
16. Jha P, Ranson MK, Nguyen SN, et al. Estimates of global and regional smoking prevalence in 1995, by age and sex. Am J Public Health 2002;92:1002-6.
17. Institute of Medicine. Cancer control priorities in low and middle-income countries. Washington: National Academy of Sciences; 2007.
18. Gaziano TA, Reddy KS, Paccaud F, et al. Cardiovascular disease. In: Jamison DT, Measham AR, Breman JB, et al, editors. Disease control priorities in developing countries. 2nd ed. New York: Oxford University Press; 2006. p. 645-62. Available: http://files.dcp2.org/pdf/DCP/DCP01.pdf (accessed 2007 Sept 24).
19. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet 1995;346:1647-53.
20. Chen ZM, Jiang LX, Chen YP, et al; COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group. Addition of Clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005;366:1607-21.
21. Chen Z, Peto R, Collins R, et al. Serum cholesterol concentration and coronary heart disease in a population with low cholesterol concentrations. BMJ 1991;303:276-82.
22. Rose G. Sick individuals and sick populations. Int J Epidemiol 1985;14:32-8.
23. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
24. Chen Z, Lee L, Chen J, et al. Cohort profile: the Kadoorie Study of chronic disease in China (KSCDC). Int J Epidemiol 2005;34:1243-9.
25. Jha P, Gajalakshmi V, Gupta PC, et al. Prospective study of one million deaths in India: rationale, design, and validation results. PLoS Med 2006;3:e18.
26. Global IDEA Scientific Advisory Committee. Health and economic benefits of an accelerated program of research to combat global infectious diseases. CMAJ 2004;171:1203-8.